Odyssey Therapeutics, Inc.
NASDAQ:ODTXBiotechnology
-$0.01 today
- Market cap
- $912.33M
- Beta
- 0.00
Volume 0.37M
Average 0.43M
ODTX Net Debt
Total debt minus cash and equivalents; a negative value means the company holds more cash than debt.
Net Debt history
Currency unavailable · from the balance sheet
No Net Debt data reported for this period type.
Net Debt vs competitors
How ODTX compares with its peers on the latest reported figures
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $28.89M USD | +134.8% | — | 8.8% | |
| Mar 2026 | -$26.68M USD | +4.3% | — | 13.4% | |
ALMSAlumis Inc. Common Stock | Jun 2026 | -$27.28M USD | +75.9% | — | 4.9% |
| Sep 2026 | -$82.73M USD | -27.5% | — | 7.5% | |
AGMBAgomAb Therapeutics N.V. American Depositary Shares | Sep 2025 | -€128.26M EUR | — | — | 77.4% |
| Mar 2026 | -$186.21M USD | -1297.0% | — | 98.1% | |
ORKAOruka Therapeutics, Inc. | Sep 2026 | -$188.59M USD | -111.1% | — | 15.3% |
| Jun 2026 | -$410.86M USD | -161.3% | — | 46.4% | |
ODTXOdyssey Therapeutics, Inc. | — | — | — | — | — |
| Peer median (excluding ODTX) | — | -27.5% | — | 14.4% | |
Competitors are the stored peer set for ODTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Odyssey Therapeutics, Inc.
NASDAQ:ODTX
Intrinsic Alpha fair value
Locked
Current Price
$18.98
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.